Saso L - Search Results

1

Editorial: Redox-signaling in neurodegenerative diseases: biomarkers, targets, and therapies.

Carvalho AN, Branco V, van Horssen J, Saso L. Carvalho AN, et al. Among authors: saso l. Front Cell Neurosci. 2023 Apr 20;17:1198669. doi: 10.3389/fncel.2023.1198669. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37153636 Free PMC article. No abstract available.

2

Editorial: Targeting redox regulation and autophagy systems for cancer therapy.

Zhang J, Semlali A, Maycotte P, Saso L. Zhang J, et al. Among authors: saso l. Front Oncol. 2023 Jan 31;13:1146670. doi: 10.3389/fonc.2023.1146670. eCollection 2023. Front Oncol. 2023. PMID: 36798822 Free PMC article. No abstract available.

3

NRF2 signaling pathway and telomere length in aging and age-related diseases.

Medoro A, Saso L, Scapagnini G, Davinelli S. Medoro A, et al. Among authors: saso l. Mol Cell Biochem. 2023 Nov 2. doi: 10.1007/s11010-023-04878-x. Online ahead of print. Mol Cell Biochem. 2023. PMID: 37917279 Review.

4

Novel potential pharmacological applications of dimethyl fumarate-an overview and update.

Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M. Bresciani G, et al. Among authors: saso l. Front Pharmacol. 2023 Sep 7;14:1264842. doi: 10.3389/fphar.2023.1264842. eCollection 2023. Front Pharmacol. 2023. PMID: 37745068 Free PMC article. Review.

5

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment.

Rahban M, Joushi S, Bashiri H, Saso L, Sheibani V. Rahban M, et al. Among authors: saso l. Front Chem. 2024 Jan 8;11:1325214. doi: 10.3389/fchem.2023.1325214. eCollection 2023. Front Chem. 2024. PMID: 38264122 Free PMC article. Review.

6

Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy.

Rojas-Solé C, Pinilla-González V, Lillo-Moya J, González-Fernández T, Saso L, Rodrigo R. Rojas-Solé C, et al. Among authors: saso l. Redox Rep. 2024 Dec;29(1):2289740. doi: 10.1080/13510002.2023.2289740. Epub 2023 Dec 18. Redox Rep. 2024. PMID: 38108325 Free PMC article. Review.

7

Melatonin as mitochondria-targeted drug.

Suzen S, Saso L. Suzen S, et al. Among authors: saso l. Adv Protein Chem Struct Biol. 2023;136:249-276. doi: 10.1016/bs.apcsb.2023.03.006. Epub 2023 Apr 22. Adv Protein Chem Struct Biol. 2023. PMID: 37437980

8

Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects.

Shahcheraghi SH, Salemi F, Small S, Syed S, Salari F, Alam W, Cheang WS, Saso L, Khan H. Shahcheraghi SH, et al. Among authors: saso l. Phytother Res. 2023 Apr;37(4):1590-1605. doi: 10.1002/ptr.7754. Epub 2023 Feb 8. Phytother Res. 2023. PMID: 36752350 Review.

9

Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications.

Gallorini M, Carradori S, Panieri E, Sova M, Saso L. Gallorini M, et al. Among authors: saso l. Antioxid Redox Signal. 2024 Apr;40(10-12):636-662. doi: 10.1089/ars.2022.0213. Epub 2023 Sep 6. Antioxid Redox Signal. 2024. PMID: 37470218 Review.

10

Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications.

Yaylim İ, Aru M, Farooqi AA, Hakan MT, Buttari B, Arese M, Saso L. Yaylim İ, et al. Among authors: saso l. Cancer Drug Resist. 2024 Feb 29;7:8. doi: 10.20517/cdr.2023.79. eCollection 2024. Cancer Drug Resist. 2024. PMID: 38434765 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page